Literature DB >> 1893632

Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease.

M C Allison1, L W Poulter.   

Abstract

Previous studies have demonstrated the presence of much more marked macrophage heterogeneity in colonic mucosa affected by the idiopathic inflammatory bowel diseases (ulcerative colitis and Crohn's disease) than in normal mucosa. This study examines the morphology, distribution and phenotypic expression of mucosal macrophage-like cells in biopsies from patients with idiopathic inflammatory bowel disease in comparison with disease control samples from patients with colonic infection or ischaemia. Approximately 80% of macrophage-like cells in histologically normal mucosa co-express the antigens recognized by the monoclonal antibodies RFD1 (an interdigitating cell marker) and RFD7 (a marker for mature tissue macrophages). In idiopathic inflammatory bowel disease, the normal colonic macrophage population is partly replaced by cells staining positively with RFD7 alone, and, to a lesser extent, with RFD1+ dendritic cells. Sections from patients with infections and ischaemia exhibited epithelial HLA-DR positivity and infiltration of the lamina propria by a more heterogeneous population of macrophages than that seen in histologically normal mucosa. However, the displacement of the normal colonic macrophage phenotype by RFD7+ tissue macrophages occurred to a significantly greater extent in idiopathic inflammatory bowel disease than in disease control mucosa. A pathognomonic feature of the ulcerative colitis and Crohn's colitis sections was the clustering of RFD9+ epithelioid cells at the bases of disrupted crypts and adjacent to areas of mucosal damage. It is concluded that a degree of macrophage heterogeneity and macrophage infiltration can occur as a non-specific response to colonic mucosal damage. The distinctive feature of idiopathic inflammatory bowel disease mucosa is the almost complete replacement of the normal colonic mucosal macrophage population by tissue macrophages and epithelioid cells, and this phenomenon may be important in promoting the development of a chronic inflammatory state.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893632      PMCID: PMC1535603          DOI: 10.1111/j.1365-2249.1991.tb05757.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Microgranulomas in grossly normal rectal mucosa in Crohn's disease.

Authors:  H Rotterdam; B I Korelitz; S C Sommers
Journal:  Am J Clin Pathol       Date:  1977-06       Impact factor: 2.493

2.  Monoclonal antibody EBM/11: high cellular specificity for human macrophages.

Authors:  P M Kelly; E Bliss; J A Morton; J Burns; J O McGee
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

3.  Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis.

Authors:  M A Spiteri; S W Clarke; L W Poulter
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

4.  Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease.

Authors:  C A Seldenrijk; H A Drexhage; S G Meuwissen; S T Pals; C J Meijer
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

5.  Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum.

Authors:  Y R Mahida; S Patel; P Gionchetti; D Vaux; D P Jewell
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

6.  The distribution of phenotypically distinct macrophage subsets in the lungs of patients with cryptogenic fibrosing alveolitis.

Authors:  B Noble; R M Du Bois; L W Poulter
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

7.  Macrophage and lymphocyte subpopulations in magnifying endoscopic lesions of Crohn's disease.

Authors:  P Gionchetti; Y R Mahida; S Patel; D P Jewell
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

8.  Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.

Authors:  Y R Mahida; S Patel; K Wu; D P Jewell
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

9.  Veiled cells in chronic idiopathic inflammatory bowel disease.

Authors:  M M Wilders; H A Drexhage; M Kokjé; H W Verspaget; S G Meuwissen
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

10.  Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis.

Authors:  W S Selby; L W Poulter; S Hobbs; D P Jewell; G Janossy
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

View more
  17 in total

Review 1.  Probiotics and immune response.

Authors:  Stephanie Blum; Dirk Haller; Andrea Pfeifer; Eduardo J Schiffrin
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

2.  Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression.

Authors:  A K Eckstein; B Quadbeck; S Tews; K Mann; C Krüger; C H Mohr; K-P Steuhl; J Esser; R K Gieseler
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

3.  Modulation of the phenotypic and functional properties of phagocytic macrophages by wear particles from orthopaedic implants.

Authors:  N Al-Saffar; P A Revell; A Kobayashi
Journal:  J Mater Sci Mater Med       Date:  1997-11       Impact factor: 3.896

4.  Possible involvement of muscularis resident macrophages in impairment of interstitial cells of Cajal and myenteric nerve systems in rat models of TNBS-induced colitis.

Authors:  Kazuya Kinoshita; Kazuhide Horiguchi; Masahiko Fujisawa; Fuyu Kobirumaki; Shigeru Yamato; Masatoshi Hori; Hiroshi Ozaki
Journal:  Histochem Cell Biol       Date:  2006-07-27       Impact factor: 4.304

5.  Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease.

Authors:  M Zareie; P K Singh; E J Irvine; P M Sherman; D M McKay; M H Perdue
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  T-cell cytokines may control the balance of functionally distinct macrophage populations.

Authors:  V J Tormey; J Faul; C Leonard; C M Burke; A Dilmec; L W Poulter
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

7.  Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.

Authors:  J Rugtveit; P Brandtzaeg; T S Halstensen; O Fausa; H Scott
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

8.  Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ.

Authors:  Y Z Almallah; S W Ewen; A El-Tahir; N A Mowat; P W Brunt; T S Sinclair; S D Heys; O Eremin
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

9.  Profile of soluble cytokine receptors in Crohn's disease.

Authors:  T Gustot; A Lemmers; E Louis; C Nicaise; E Quertinmont; J Belaiche; S Roland; A Van Gossum; J Devière; D Franchimont
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

10.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Authors:  Ryan Ungaro; Masayuki Fukata; David Hsu; Yasmin Hernandez; Keith Breglio; Anli Chen; Ruliang Xu; John Sotolongo; Cecillia Espana; Julia Zaias; Greg Elson; Lloyd Mayer; Marie Kosco-Vilbois; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.